An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.

Viruses · 2020 · PMC7290679 · PMID 32443728

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

PLGA-EVG NPs also showed a trend of decreasing viral load in the CNS in the humanized HIVE mice model, as compared with the EVG native drug.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.